TY - JOUR
T1 - Incidental renal artery stenosis among a prospective cohort of hypertensive patients undergoing coronary angiography
AU - Rihal, Charanjit S.
AU - Textor, Stephen C.
AU - Breen, Jerome F.
AU - McKusick, Michael A.
AU - Grill, Diane E.
AU - Hallett, John W.
AU - Holmes, David R.
PY - 2002
Y1 - 2002
N2 - Objective: To determine the feasibility, safety, and clinical yield of angiographic screening among hypertensive patients undergoing coronary angiography. Patients and Methods: This study was a prospective cohort analysis of hypertensive patients who underwent cardiac catheterization at a tertiary care referral center from July 1998 to March 1999. Abdominal aortography was performed to screen for renal artery stenosis, the percentage of which was measured. Results: The mean ± SD age of the 297 study patients was 64.9±10.2 years; 58.6% were male, and 98.0% were white. Mean ± SD systolic/diastolic blood pressure was 142.8±22.5/79.6±11.4 mm Hg. Aortography required a mean incremental dose of 62±9 mL of nonionic contrast agent. No complications were attributable to aortography. Of 680 renal arteries, 611 (90%) were visualized adequately. Also, 53% of patients had normal renal arteries, 28% had stenoses less than 50%, and 19.2% had stenoses of 50% or more. Renal artery stenosis was bilateral in 3.7% of patients and high grade (>70% stenosis) in 7%. Patients with renal artery stenosis were more likely to have had a previous coronary intervention. In multivariate analysis, systolic blood pressure (odds ratio [OR], 1.2; 95% confidence interval [CI], 1.03-1.38; P=.02), history of stroke or transient ischemic attack (OR, 2.7; 95% CI, 1.27-5.78; P=.01), and cancer (OR, 2.0; 95% CI, 1.02-3.82; P=.04) independently correlated with renal artery stenosis of 50% or more. Conclusion: The prevalence of incidental renal artery stenosis among hypertensive patients undergoing coronary catheterization is significant. Therefore, screening abdominal aortography should be considered in these patients to better define their risk of cardiovascular complications.
AB - Objective: To determine the feasibility, safety, and clinical yield of angiographic screening among hypertensive patients undergoing coronary angiography. Patients and Methods: This study was a prospective cohort analysis of hypertensive patients who underwent cardiac catheterization at a tertiary care referral center from July 1998 to March 1999. Abdominal aortography was performed to screen for renal artery stenosis, the percentage of which was measured. Results: The mean ± SD age of the 297 study patients was 64.9±10.2 years; 58.6% were male, and 98.0% were white. Mean ± SD systolic/diastolic blood pressure was 142.8±22.5/79.6±11.4 mm Hg. Aortography required a mean incremental dose of 62±9 mL of nonionic contrast agent. No complications were attributable to aortography. Of 680 renal arteries, 611 (90%) were visualized adequately. Also, 53% of patients had normal renal arteries, 28% had stenoses less than 50%, and 19.2% had stenoses of 50% or more. Renal artery stenosis was bilateral in 3.7% of patients and high grade (>70% stenosis) in 7%. Patients with renal artery stenosis were more likely to have had a previous coronary intervention. In multivariate analysis, systolic blood pressure (odds ratio [OR], 1.2; 95% confidence interval [CI], 1.03-1.38; P=.02), history of stroke or transient ischemic attack (OR, 2.7; 95% CI, 1.27-5.78; P=.01), and cancer (OR, 2.0; 95% CI, 1.02-3.82; P=.04) independently correlated with renal artery stenosis of 50% or more. Conclusion: The prevalence of incidental renal artery stenosis among hypertensive patients undergoing coronary catheterization is significant. Therefore, screening abdominal aortography should be considered in these patients to better define their risk of cardiovascular complications.
UR - http://www.scopus.com/inward/record.url?scp=0036195667&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036195667&partnerID=8YFLogxK
U2 - 10.4065/77.4.309
DO - 10.4065/77.4.309
M3 - Article
C2 - 11936924
AN - SCOPUS:0036195667
SN - 0025-6196
VL - 77
SP - 309
EP - 316
JO - Mayo Clinic proceedings
JF - Mayo Clinic proceedings
IS - 4
M1 - 61782
ER -